Clinical Trial Update: Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating platinum-based chemotherapy with or without INCMGA00012 (retifanlimab) in metastatic non-small cell lung cancer has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-squamous Non-small Cell Lung Cancer
• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Retifanlimab (retifanlimab)

Snippet

Sponsor: Incyte Corporation | Conditions: Metastatic Squamous Non-Small Cell Lung Cancer, Metastatic Nonsquamous Non-Small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-02-06